Wave Life Sciences (WVE) Leases (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Leases for 10 consecutive years, with $12.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases fell 30.29% year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2025, down 30.29%, and an annual FY2025 reading of $12.5 million, down 30.29% over the prior year.
- Leases was $12.5 million for Q4 2025 at Wave Life Sciences, down from $13.9 million in the prior quarter.
- Across five years, Leases topped out at $27.8 million in Q3 2022 and bottomed at $12.0 million in Q2 2022.
- Average Leases over 5 years is $19.1 million, with a median of $18.1 million recorded in 2021.
- The sharpest move saw Leases surged 106.71% in 2023, then tumbled 30.29% in 2025.
- Year by year, Leases stood at $18.4 million in 2021, then surged by 46.06% to $26.8 million in 2022, then dropped by 15.67% to $22.6 million in 2023, then decreased by 21.06% to $17.9 million in 2024, then crashed by 30.29% to $12.5 million in 2025.
- Business Quant data shows Leases for WVE at $12.5 million in Q4 2025, $13.9 million in Q3 2025, and $15.2 million in Q2 2025.